Picture of Teladoc Health logo

TDOC Teladoc Health Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Annual income statement for Teladoc Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5531,0942,0332,4072,602
Cost of Revenue
Gross Profit3697031,3821,6631,842
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses6341,6092,34216,0602,851
Operating Profit-80.4-515-309-13,653-249
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-109-576-385-13,663-220
Provision for Income Taxes
Net Income After Taxes-98.9-485-429-13,660-220
Net Income Before Extraordinary Items
Net Income-98.9-485-429-13,660-220
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-98.9-485-429-13,660-220
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.32-4.66-2.44-30.6-1.19